Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Abstract Background The lack of an antidote against factor Xa inhibitors in case of major bleeding or need for urgent surgery is a concern to clinicians. Guidelines on managing major bleeding in patients under anticoagulation with a factor Xa inhibitor suggest several hemostatic agents to reverse th...
Main Authors: | Nina Haagenrud Schultz, Runar Lundblad, Pål Andre Holme |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-018-1660-9 |
Similar Items
-
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra
by: Herm Jan M. Brinkman, et al.
Published: (2022-07-01) -
International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
by: Fanny Ofek, et al.
Published: (2019-10-01) -
Anticoagulant activity of apixaban can be estimated by multiple regression analysis
by: Naoko Unami, et al.
Published: (2020-12-01) -
A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01) -
Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
by: Herm Jan M. Brinkman, et al.
Published: (2022-03-01)